Tower Research Capital (TRC)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Tower Research Capital (TRC)’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,421	Closed	-$10K	–	6670
2023 Q1	$10K	Sell	6,421 -1,339	-17%	-$2.72K	﹤0.01%	4458
2022 Q4	$15K	Buy	7,760 +7,585	+4,334%	+$18.7K	﹤0.01%	3477
2022 Q3	$1K	Sell	175 -12,158	-99%	-$46.4K	﹤0.01%	5994
2022 Q2	$42K	Buy	12,333 +11,839	+2,397%	+$65.3K	﹤0.01%	3071
2022 Q1	$5K	Buy	+494	New	+$7.51K	﹤0.01%	5169
2021 Q4	–	Sell	-1,281	Closed	-$42K	–	6967
2021 Q3	$42K	Sell	1,281 -324	-20%	-$11.9K	﹤0.01%	3105
2021 Q2	$67K	Buy	1,605 +1,308	+440%	+$67K	﹤0.01%	2775
2021 Q1	$19K	Sell	297 -745	-71%	-$52K	﹤0.01%	3945
2020 Q4	$68K	Sell	1,042 -1,115	-52%	-$72.7K	﹤0.01%	2774
2020 Q3	$117K	Buy	2,157 +1,748	+427%	+$134K	﹤0.01%	3033
2020 Q2	$39K	Buy	409 +37	+10%	+$2.76K	﹤0.01%	3256
2020 Q1	$19K	Buy	+372	New	+$38.9K	﹤0.01%	1752
2019 Q4	–	Sell	-43	Closed	-$3K	–	4691
2019 Q3	$3K	Sell	43 -116	-73%	-$12.4K	﹤0.01%	3622
2019 Q2	$20K	Buy	+159	New	+$22.9K	﹤0.01%	2196
2019 Q1	–	Sell	-311	Closed	-$34K	–	4524
2018 Q4	$34K	Sell	311 -2	-0.6%	-$261	﹤0.01%	1559
2018 Q3	$42K	Buy	313 +248	+382%	+$34.2K	﹤0.01%	1879
2018 Q2	$9K	Sell	65 -1,318	-95%	-$181K	﹤0.01%	2851
2018 Q1	$191K	Buy	1,383 +581	+72%	+$79.1K	0.02%	906
2017 Q4	$99K	Buy	802 +58	+8%	+$7.96K	0.01%	879
2017 Q3	$102K	Buy	744 +736	+9,200%	+$111K	0.01%	1337
2017 Q2	$1K	Sell	8 -96	-92%	-$13.7K	﹤0.01%	2547
2017 Q1	$13K	Buy	104 +92	+767%	+$9.57K	﹤0.01%	1614
2016 Q4	$1K	Buy	+12	New	+$1.1K	﹤0.01%	3693
2016 Q3	–	Sell	-95	Closed	-$10K	–	4748
2016 Q2	$10K	Buy	95 +38	+67%	+$4.45K	﹤0.01%	2852
2016 Q1	$7K	Sell	57 -63	-53%	-$6.62K	﹤0.01%	2432
2015 Q4	$14K	Buy	+120	New	+$15.5K	﹤0.01%	1726
2015 Q3	–	Sell	-421	Closed	-$82K	–	5039
2015 Q2	$82K	Buy	421 +216	+105%	+$40.1K	0.01%	1001
2015 Q1	$31K	Buy	205 +197	+2,463%	+$30K	﹤0.01%	1887
2014 Q4	$1K	Sell	8 -328	-98%	-$47.2K	﹤0.01%	3777
2014 Q3	$48K	Buy	336 +254	+310%	+$36.8K	0.01%	1565
2014 Q2	$11K	Buy	+82	New	+$10.4K	﹤0.01%	2304
2013 Q4	–	Sell	-23	Closed	-$2K	–	5051
2013 Q3	$2K	Sell	23 -84	-79%	-$9.53K	﹤0.01%	4174
2013 Q2	$12K	Buy	+107	New	+$13.1K	﹤0.01%	2220

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Tower Research Capital (TRC)'s SRGA Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 6,421 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in SRGA in Q2 2013 and held it in 33 quarters. The position peaked at $191K in Q1 2018. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Tower Research Capital (TRC) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 6,421 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $10K.
Tower Research Capital (TRC) first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 33 quarters.
Tower Research Capital (TRC)'s Surgalign Holdings, Inc. Common Stock position peaked at $191K in Q1 2018.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.